These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up. Nakagawa T; Kami M; Hori A; Kim SW; Murashige N; Hamaki T; Kishi Y; Fujimoto H; Matsuoka N; Okajima E; Komiyama M; Tobisu K; Wakayama T; Uike N; Tajima K; Makimoto A; Mori S; Tanosaki R; Takaue Y; Kakizoe T Exp Hematol; 2004 Jul; 32(7):599-606. PubMed ID: 15246155 [TBL] [Abstract][Full Text] [Related]
7. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Schulenburg A; Turetschek K; Wrba F; Vogelsang H; Greinix HT; Keil F; Mitterbauer M; Kalhs P Ann Hematol; 2004 Feb; 83(2):101-6. PubMed ID: 14615909 [TBL] [Abstract][Full Text] [Related]
8. Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment? Roigas J; Massenkeil G World J Urol; 2005 Jul; 23(3):213-20. PubMed ID: 15685446 [TBL] [Abstract][Full Text] [Related]
9. Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity. Massenkeil G; Roigas J; Nagy M; Wille A; Stroszczynski C; Mapara MY; Loening S; Dörken B; Arnold R Bone Marrow Transplant; 2004 Aug; 34(4):309-16. PubMed ID: 15220955 [TBL] [Abstract][Full Text] [Related]
10. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
11. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy. Ueno NT; Cheng YC Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451 [No Abstract] [Full Text] [Related]
12. Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma. Roigas J; Johannsen M; Ringsdorf M; Massenkeil G Expert Rev Anticancer Ther; 2006 Oct; 6(10):1449-58. PubMed ID: 17069529 [TBL] [Abstract][Full Text] [Related]
13. What's new in the treatment of metastatic kidney cancer? Mancuso A; Sternberg CN BJU Int; 2005 Jun; 95(9):1171-80. PubMed ID: 15892796 [No Abstract] [Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]